{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:15:21Z","timestamp":1777990521187,"version":"3.51.4"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:00:00Z","timestamp":1773446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) have been evaluated as an alternative to S100 calcium binding protein B (S100B), which is mentioned in the Scandinavian guideline for managing mild traumatic brain injury (mTBI). Preanalytical, analytical and diagnostic performance of GFAP\/UCH-L1 must be assessed before clinical use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>GFAP\/UCH-L1 were quantified using the TBI assay on Abbott Alinity. Precision was estimated using internal quality controls, and matrix effects were evaluated using serum and plasma from 30 outpatients. Repeatability and stability at different conditions (25, 4, \u221220, and \u221280\u00b0C) were evaluated on serum and plasma. GFAP and UCH-L1 serum levels in 30 healthy individuals were determined and compared to S100B levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Inter-instrumental precision was \u22644.2% for both biomarkers. Random outliers were observed for UCH-L1 in plasma, where 5 measurements deviated &amp;gt;25%. Acceptable storage stability was found for GFAP and UCH-L1. All healthy individuals had GFAP values within the manufacturer\u2019s reference interval (6.6 to 70.9\u2005ng\/L) and two exceeded the upper limit for UCH-L1 (44.7 to 226.8\u2005ng\/L). Four healthy individuals (13%) had GFAP results above cutoff without S100B exceeding its cutoff, while one individual had values of S100B above cutoff but GFAP below cutoff.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The analytical precision and storage conditions of GFAP\/UCH-L1 were satisfactory. Serum and plasma can be used for measurement of GFAP, whereas UCH-L1 measurement in plasma is not advised until further evaluations are conducted. The manufacturer\u2019s upper reference limits may not be suitable for our population. Thorough research on cutoff values is necessary.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jalm\/jfag021","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:33:25Z","timestamp":1770640405000},"page":"446-459","source":"Crossref","is-referenced-by-count":0,"title":["GFAP\/UCH-L1 Assay for mTBI: Preanalytical Factors and Levels in Healthy Individuals\u2014A Study on Danish Adults"],"prefix":"10.1093","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-1710","authenticated-orcid":false,"given":"Ida","family":"Boegh Andersen","sequence":"first","affiliation":[{"name":"Unit of Biochemistry, Department of Clinical Diagnostics, University Hospital of Southern Denmark , Esbjerg ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Lindegaard","family":"Christiansen","sequence":"additional","affiliation":[{"name":"Department of Blood Tests, Biochemistry and Immunology, University Hospital of Southern Denmark , Aabenraa ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maj-Britt","family":"Fruekilde","sequence":"additional","affiliation":[{"name":"Department of Blood Tests, Biochemistry and Immunology, University Hospital of Southern Denmark , Aabenraa ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Rosenberg","sequence":"additional","affiliation":[{"name":"Unit of Biochemistry, Department of Clinical Diagnostics, University Hospital of Southern Denmark , Esbjerg ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,14]]},"reference":[{"key":"2026050509525151400_jfag021-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-016-0723-z","article-title":"The addition of S100B to guidelines for management of mild head injury is potentially cost saving","volume":"16","author":"Calcagnile","year":"2016","journal-title":"BMC Neurol"},{"key":"2026050509525151400_jfag021-B2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1474-4422(18)30231-X","article-title":"Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study","volume":"17","author":"Bazarian","year":"2018","journal-title":"Lancet Neurol"},{"key":"2026050509525151400_jfag021-B3","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/02699052.2015.1091504","article-title":"Reducing head computed tomography after mild traumatic brain injury: screening value of clinical findings and S100B protein levels","volume":"30","author":"Asadollahi","year":"2016","journal-title":"Brain Inj"},{"key":"2026050509525151400_jfag021-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13049-021-00891-5","article-title":"Diagnostic accuracy of prehospital serum S100B and GFAP in patients with mild traumatic brain injury: a prospective observational multicenter cohort study\u2014the PreTBI I study","volume":"29","author":"Seidenfaden","year":"2021","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2026050509525151400_jfag021-B5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1741-7015-11-50","article-title":"Scandinavian guidelines for initial management of minimal, mild and moderate head injuries in adults: an evidence and consensus-based update","volume":"11","author":"Und\u00e9n","year":"2013","journal-title":"BMC Med"},{"key":"2026050509525151400_jfag021-B6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10143-021-01678-z","article-title":"S100b, GFAP, UCH-L1 and NSE as predictors of abnormalities on CT imaging following mild traumatic brain injury: a systematic review and meta-analysis of diagnostic test accuracy","volume":"45","author":"Amoo","year":"2022","journal-title":"Neurosurg Rev"},{"key":"2026050509525151400_jfag021-B7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/00365513.2024.2392247","article-title":"Comparison of sample materials for S100b analysis","volume":"84","author":"Nielsen","year":"2024","journal-title":"Scand J Clin Lab Invest"},{"key":"2026050509525151400_jfag021-B8","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/clinchem\/hvae049","article-title":"Blood biomarkers for the management of mild traumatic brain injury in clinical practice","volume":"70","author":"Oris","year":"2024","journal-title":"Clin Chem"},{"key":"2026050509525151400_jfag021-B9","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1097\/CCM.0000000000003728","article-title":"Prognostic value of glial fibrillary acidic protein in patients with moderate and severe traumatic brain injury: a systematic review and meta-analysis","volume":"47","author":"Shemilt","year":"2019","journal-title":"Crit Care Med"},{"key":"2026050509525151400_jfag021-B10","doi-asserted-by":"crossref","first-page":"102785","DOI":"10.1016\/j.ebiom.2020.102785","article-title":"Blood biomarkers on admission in acute traumatic brain injury: relations to severity, CT findings and care path in the CENTER-TBI study","volume":"56","author":"Czeiter","year":"2020","journal-title":"EBioMedicine"},{"key":"2026050509525151400_jfag021-B11","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1515\/cclm-2023-1238","article-title":"S100b vs. \u201cGFAP and UCH-L1\u201d assays in the management of mTBI patients","volume":"62","author":"Oris","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"2026050509525151400_jfag021-B12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1515\/cclm-2020-0061","article-title":"The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)","volume":"59","author":"Cornes","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"2026050509525151400_jfag021-B13","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1515\/cclm-2022-0646","article-title":"Serum GFAP\u2014reference interval and preanalytical properties in Danish adults","volume":"60","author":"Tybirk","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026050509525151400_jfag021-B14","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1515\/cclm-2022-0480","article-title":"Short-term biological variation of serum glial fibrillary acidic protein","volume":"60","author":"Christensen","year":"2022","journal-title":"Clin Chem Lab Med"},{"key":"2026050509525151400_jfag021-B15","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/alz.13518","article-title":"Biological variation estimates of Alzheimer's disease plasma biomarkers in healthy individuals","volume":"20","author":"Brum","year":"2024","journal-title":"Alzheimers Dement"},{"key":"2026050509525151400_jfag021-B16","author":"Aarsand"},{"key":"2026050509525151400_jfag021-B17"},{"key":"2026050509525151400_jfag021-B18","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1089\/neu.2018.6053","article-title":"Stability of blood biomarkers of traumatic brain injury","volume":"36","author":"Rezaii","year":"2019","journal-title":"J Neurotrauma"},{"key":"2026050509525151400_jfag021-B19","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1515\/cclm-2024-1034","article-title":"Increased specificity of the \u201cGFAP\/UCH-L1\u201d mTBI rule-out test by age dependent cut-offs","volume":"63","author":"Ladang","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"2026050509525151400_jfag021-B20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12245-024-00708-z","article-title":"Evaluation of GFAP\/UCH-L1 biomarkers for computed tomography exclusion in mild traumatic brain injury (mTBI)","volume":"17","author":"Legramante","year":"2024","journal-title":"Int J Emerg Med"},{"key":"2026050509525151400_jfag021-B21","author":"Hanse"},{"key":"2026050509525151400_jfag021-B22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13049-025-01364-9","article-title":"A head-to-head comparison of S100B and GFAP\/UCH-L1 for detection of traumatic intracranial lesions in a Scandinavian trauma cohort","volume":"33","author":"Wichmann","year":"2025","journal-title":"Scand J Trauma Resusc Emerg Med"}],"container-title":["The Journal of Applied Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/3\/446\/67342518\/jfag021.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jalm\/article-pdf\/11\/3\/446\/67342518\/jfag021.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T13:52:59Z","timestamp":1777989179000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jalm\/article\/11\/3\/446\/8519599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,14]]},"published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jalm\/jfag021","relation":{},"ISSN":["2475-7241"],"issn-type":[{"value":"2475-7241","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,3,14]]}}}